KLRK1 and neoplasm: Nkg2d neutralizing antibody32 inhibited the suppression of both target and non-target tumor growth induced by the HVJ-E/OX40 antibody (target, p = 0.0315; non-target, p < 0.0001; Figures 7D and 7E).